Certain Bulk Drug Substances Use in Compounding Present Significant Safety Risks
Postedabout 2 months agoActiveabout 2 months ago
fda.govResearchstory
calmnegative
Debate
20/100
FdaDrug CompoundingPharmaceutical Safety
Key topics
Fda
Drug Compounding
Pharmaceutical Safety
The FDA warns that certain bulk drug substances used in compounding may pose significant safety risks to patients. The agency has identified specific substances that are not suitable for compounding due to potential health hazards.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
4m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Nov 15, 2025 at 10:57 AM EST
about 2 months ago
Step 01 - 02First comment
Nov 15, 2025 at 11:01 AM EST
4m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Nov 15, 2025 at 11:01 AM EST
about 2 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
Discussion (1 comments)
Showing 1 comments
randycupertinoAuthor
about 2 months ago
Timely press release given the current popularity of the cheaper options of compounding GLP-1s and this admin's recent cozying up with Novo Nordisk and Eli Lilly.
View full discussion on Hacker News
ID: 45938254Type: storyLast synced: 11/17/2025, 4:10:17 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.